Literature DB >> 32405929

The use of computed tomography as a first-line imaging modality in patients with primary hyperparathyroidism.

Mechteld C de Jong1, K Jamal2, S Morley3, T Beale3, T Chung4, S Jawad3, S Hurel4, H Simpson4, U Srirangalingam4, S E Baldeweg4, V Rozalén García2, S Otero3, M Shawky2, T E Abdel-Aziz2, T R Kurzawinski2.   

Abstract

BACKGROUND: The success of minimally invasive parathyroidectomy (MIP) relies on accurate localization of the abnormal parathyroid glands. Concordant findings on ultrasound (US) and 99mTc-scintigraphy (sestamibi) are currently considered the 'gold standard'. Computed tomography (CT) has also recently been used in preoperative planning. We sought to assess the accuracy of CT for localization of abnormal parathyroid glands in such patients.
METHODS: An audit of 75 patients with primary hyperparathyroidism (PHPT) who underwent neck US and CT between 2017 and 2019 at our center as their first-line imaging.
RESULTS: All 75 patients underwent US and CT and 54 (72.0%) also had sestamibi. CT alone identified a potential target in all patients, of which the location was correct in 63 (84.0%). The overall combined sensitivity of US and CT was 88% (95% CI 78-94) and was higher than the combined sensitivity of US and sestamibi (65% [95% CI 53-76]; p < 0.001). Twenty-one patients (28.0%) had an ectopic gland, and the sensitivity of US and CT was 86% (95% CI 64-96) versus US and sestamibi (57% [95% CI 34-77]; p = 0.016). For adenomas < 1.0 g (n = 36; 48%), the accuracy of CT was 81% (95% CI 64-91) compared with 62% (95% CI 44-77) for US and sestamibi (p = 0.04). The correct preoperative diagnosis of multiglandular disease (n = 9; 12%) seemed to be the most difficult, with similar accuracy for US and sestamibi (40% [95% CI 14-73]) and US and CT (50% [95% CI 20-80]) (p > 0.99).
CONCLUSION: The combination of US and CT was able to correctly identify the location of the abnormal parathyroid in 88% of patients and, in comparison with US and sestamibi, had better diagnostic accuracy, especially for smaller and ectopic adenomas. This finding suggests that US and CT could be considered as a first-line imaging modality in patients with PHPT considered for MIP.
© 2020. Hellenic Endocrine Society.

Entities:  

Keywords:  Imaging; Localization; Minimally invasive parathyroidectomy; Primary hyperparathyroidism

Mesh:

Substances:

Year:  2020        PMID: 32405929     DOI: 10.1007/s42000-020-00205-x

Source DB:  PubMed          Journal:  Hormones (Athens)        ISSN: 1109-3099            Impact factor:   2.885


  48 in total

1.  First parathyroid surgeon: Sir John Bland-Sutton and the parathyroids.

Authors:  Leigh W Delbridge; Fausto F Palazzo
Journal:  ANZ J Surg       Date:  2007-12       Impact factor: 1.872

2.  The utility of 4-dimensional computed tomography for preoperative localization of primary hyperparathyroidism in patients not localized by sestamibi or ultrasonography.

Authors:  Kristopher M Day; Mohammad Elsayed; Michael D Beland; Jack M Monchik
Journal:  Surgery       Date:  2015-02-07       Impact factor: 3.982

Review 3.  Diagnostic performance of computed tomography for parathyroid adenoma localization; a systematic review and meta-analysis.

Authors:  Wouter P Kluijfhout; Jesse D Pasternak; Toni Beninato; Frederick Thurston Drake; Jessica E Gosnell; Wen T Shen; Quan-Yang Duh; Isabel E Allen; Menno R Vriens; Bart de Keizer; Thomas A Hope; Insoo Suh
Journal:  Eur J Radiol       Date:  2017-01-05       Impact factor: 3.528

4.  Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography.

Authors:  Steven E Rodgers; George J Hunter; Leena M Hamberg; Dawid Schellingerhout; David B Doherty; Gregory D Ayers; Suzanne E Shapiro; Beth S Edeiken; Mylene T Truong; Douglas B Evans; Jeffrey E Lee; Nancy D Perrier
Journal:  Surgery       Date:  2006-10-02       Impact factor: 3.982

5.  A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism.

Authors:  Kevin Cheung; Tracy S Wang; Forough Farrokhyar; Sanziana A Roman; Julie A Sosa
Journal:  Ann Surg Oncol       Date:  2011-06-28       Impact factor: 5.344

6.  Are additional localization studies and referral indicated for patients with primary hyperparathyroidism who have negative sestamibi scan results?

Authors:  Dina M Elaraj; Rebecca S Sippel; Sheila Lindsay; Ileana Sansano; Quan-Yang Duh; Orlo H Clark; Electron Kebebew
Journal:  Arch Surg       Date:  2010-06

7.  The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism.

Authors:  Scott M Wilhelm; Tracy S Wang; Daniel T Ruan; James A Lee; Sylvia L Asa; Quan-Yang Duh; Gerard M Doherty; Miguel F Herrera; Janice L Pasieka; Nancy D Perrier; Shonni J Silverberg; Carmen C Solórzano; Cord Sturgeon; Mitchell E Tublin; Robert Udelsman; Sally E Carty
Journal:  JAMA Surg       Date:  2016-10-01       Impact factor: 14.766

8.  Comparison of 4D CT, ultrasonography, and 99mTc sestamibi SPECT/CT in localizing single-gland primary hyperparathyroidism.

Authors:  Yong Joon Suh; June Young Choi; Su-jin Kim; In Kook Chun; Tae Jin Yun; Kyu Eun Lee; Ji-hoon Kim; Gi Jeong Cheon; Yeo-Kyu Youn
Journal:  Otolaryngol Head Neck Surg       Date:  2014-12-17       Impact factor: 3.497

Review 9.  Clinical review: Parathyroid localization and implications for clinical management.

Authors:  John W Kunstman; Jonathan D Kirsch; Amit Mahajan; Robert Udelsman
Journal:  J Clin Endocrinol Metab       Date:  2013-01-23       Impact factor: 5.958

10.  Four-dimensional computed tomography scan utility in parathyroidectomy for primary hyperparathyroidism with low baseline intact parathyroid hormone.

Authors:  Anaïs Rameau; Soo Eng; Joseph Vu; Ramin Saket; Peter Jun; Michael Friduss
Journal:  Laryngoscope       Date:  2016-08-12       Impact factor: 3.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.